Filing Details

Accession Number:
0001572426-16-000166
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-17 12:15:31
Reporting Period:
2016-03-03
Filing Date:
2016-03-17
Accepted Time:
2016-03-17 12:15:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1618561 Nexvet Biopharma Plc NVET Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1632385 T Geraldine Farrell C/O Nexvet Biopharma Plc
Unit 5, Sragh Technology Park, Rahan Rd
Tullamore L2 R35 FR98
Vp Operations, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2016-03-03 132 $3.27 0 No 4 S Indirect Nexvet EBT Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Nexvet EBT Limited
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 21,253 Indirect Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C>
Ordinary Shares 4,300 Direct
Footnotes
  1. The reporting person has sole voting and dispositive power over the reported securities pursuant to that certain Nominee Deed dated as of 11/14/14 by and between Nexvet EBT Limited and the persons named in the schedule thereto. Such Nominee Deed was executed in connection with the Issuer's November 2014 four-for-five share consolidation.
  2. The reporting person and her spouse have shared voting and dispositive power with respect to these reported securities.